These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 31537508)

  • 1. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
    Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
    Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholestasis related to vanishing bile duct syndrome in Hodgkin's disease.
    Gottrand F; Cullu F; Mazingue F; Nelken B; Lecomte-Houcke M; Farriaux JP
    J Pediatr Gastroenterol Nutr; 1997 Apr; 24(4):430-3. PubMed ID: 9144127
    [No Abstract]   [Full Text] [Related]  

  • 3. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review.
    Bakhit M; McCarty TR; Park S; Njei B; Cho M; Karagozian R; Liapakis A
    World J Gastroenterol; 2017 Jan; 23(2):366-372. PubMed ID: 28127210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen.
    Bak H; Kim H; Lee S; Lee Y; Bang SM; Lee YS
    Yonsei Med J; 2020 Dec; 61(12):1060-1063. PubMed ID: 33251781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanishing bile duct syndrome as a manifestation of Hodgkin's lymphoma: a case report and review of the literature.
    Nader K; Mok S; Kalra A; Harb A; Schwarting R; Ferber A
    Tumori; 2013; 99(4):e164-8. PubMed ID: 24326854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vanishing bile duct syndrome and immunodeficiency preceding the diagnosis of Hodgkin lymphoma.
    Yeh P; Lokan J; Anantharajah A; Grigg A
    Intern Med J; 2014 Dec; 44(12a):1240-4. PubMed ID: 25442758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin's lymphoma, fully reversible after chemotherapy.
    Leeuwenburgh I; Lugtenburg EP; van Buuren HR; Zondervan PE; de Man RA
    Eur J Gastroenterol Hepatol; 2008 Feb; 20(2):145-7. PubMed ID: 18188038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholestasis secondary to Hodgkin's disease: report of 2 cases of vanishing bile duct syndrome.
    de Medeiros BC; Lacerda MA; Telles JE; da Silva JA; de Medeiros CR
    Haematologica; 1998 Nov; 83(11):1038-40. PubMed ID: 9864926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vanishing bile duct syndrome: a possible mechanism for intrahepatic cholestasis in Hodgkin's lymphoma.
    Hubscher SG; Lumley MA; Elias E
    Hepatology; 1993 Jan; 17(1):70-7. PubMed ID: 7678577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of brentuximab vedotin to a Hodgkin lymphoma patient with liver dysfunction due to vanishing bile duct syndrome resulting in a partial response without any severe adverse events.
    Ishitsuka K; Yokoyama Y; Baba N; Matsuoka R; Sakamoto N; Sakamoto T; Kusakabe M; Kato T; Kurita N; Nishikii H; Sakata-Yanagimoto M; Obara N; Hasegawa Y; Chiba S
    J Clin Exp Hematop; 2022 Sep; 62(3):154-157. PubMed ID: 35831099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vanishing Bile Duct Syndrome in the Presence of Hodgkin Lymphoma.
    Gaudel P; Brown P; Byrd K
    Cureus; 2022 Jul; 14(7):e26842. PubMed ID: 35974868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanishing Bile Duct Syndrome Secondary to Hodgkin Lymphoma in a Child.
    Palla Velangini S; Boddu D; Balakumar S; Premanand A; Kishore R; Mathew LG
    J Pediatr Hematol Oncol; 2022 Aug; 44(6):e945-e947. PubMed ID: 35796591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholestatic liver disease with ductopenia (vanishing bile duct syndrome) in Hodgkin's disease: report of a case.
    Guliter S; Erdem O; Isik M; Yamac K; Uluoglu O
    Tumori; 2004; 90(5):517-20. PubMed ID: 15656342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vanishing bile duct syndrome temporally associated with ibuprofen use.
    Alam I; Ferrell LD; Bass NM
    Am J Gastroenterol; 1996 Aug; 91(8):1626-30. PubMed ID: 8759674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vanishing bile duct syndrome in a Hodgkin's lymphoma patient with fatal outcome despite lymphoma remission.
    Aleem A; Al-Katari M; Alsaleh K; AlSwat K; Al-Sheikh A
    Saudi J Gastroenterol; 2013; 19(6):286-9. PubMed ID: 24195983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vanishing bile duct syndrome-related jaundice as the first presentation of Hodgkin lymphoma.
    Mellat-Ardakani M; Salahshour F; Rafsanjani K; Avanaki FA; Azizi M
    Radiol Case Rep; 2023 Sep; 18(9):3291-3294. PubMed ID: 37483375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
    Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
    Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid treatment of vanishing bile duct syndromes.
    Pusl T; Beuers U
    World J Gastroenterol; 2006 Jun; 12(22):3487-95. PubMed ID: 16773706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.